Just the facts. No fluff. RSS · About
NEW YORK Tuesday, November 3, 2026

Health

Blood Pressure Medication Recall: 3,528 Bottles Recalled

FDA recalls specific lots of blood pressure medication due to quality issues.

New York Editorial News Desk November 2, 2026 1 min read

The Brief

  • FDA recalls specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets.
  • Recall covers 3,528 30-count bottles and 216 90-count bottles from lot 12251163A and B.
  • Medication failed dissolution testing, leading to a Class II recall.

The U.S. Food and Drug Administration (FDA) has recalled specific lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets due to failure to meet federal quality standards.

The affected products include 3,528 30-count bottles from lot 12251163A and 216 90-count bottles from lot 12251163B, both of which expire on May 31, 2027.

Consumers are advised to check their prescription bottles for the lot number and National Drug Code (NDC). The 30-count bottles have NDC 33342-246-07, and the 90-count bottles have NDC 33342-246-10.

The FDA classified the recall as a Class II recall, indicating that use of the affected medication may cause temporary or reversible health issues, though serious consequences are considered unlikely.

Macleods Pharma USA initiated the recall on October 7, and the FDA classified it on October 26. The recall is ongoing and affects products distributed nationwide.

This recall follows another blood pressure medication recall weeks earlier, where similar quality issues led to the removal of a different drug from shelves.

More in Health